Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus cyclosporin after bilateral lung transplantation for prevention of chronic lung allograft dysfunction
2015-004137-27Phase 4Terminated
- Sponsor
- Sahlgrenska University Hospital
- Start
- Feb 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic lung allograft dysfunction (CLAD) comparing Once-daily tacrolimus with Twice-daily cyclosporin (2 arms). Primary endpoint: Cumulative incidence of chronic lung allograft dysfunction at 36 months. Started Feb 2016; status: terminated.
02
Drugs
tacrolimuscyclosporine
03
Conditions
chronic lung allograft dysfunction (CLAD)
Beyond the preview
Go deeper on 2015-004137-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004137-27.